Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories
Giulia Castellani(Italian Institute of Technology), Francesco Papaleo(Italian Institute of Technology), Andrea Armirotti(Italian Institute of Technology), Céline Devroye(Italian Institute of Technology), Giada Pacinelli(Italian Institute of Technology), Marco Nigro(Italian Institute of Technology), Arianna Benedetti(Italian Institute of Technology), Marta Busnelli(National Research Council), Clarissa Braccia(Italian Institute of Technology), Gabriella Contarini(Italian Institute of Technology), Sara Sannino(Italian Institute of Technology), Federica Maltese(Italian Institute of Technology), Camilla Paolini(National Research Council), Sara De Martin(University of Padua), Gabriella Trigilio(Italian Institute of Technology), Mariasole Ciampoli(Italian Institute of Technology), Valentina Ferretti(Italian Institute of Technology), Fabio Bertozzi(Italian Institute of Technology), Weronika Barcik(Italian Institute of Technology), Francesca Managò(Italian Institute of Technology), Bice Chini(Neuroscience Institute), Federica Antonelli(Italian Institute of Technology), Ennio Albanesi(Italian Institute of Technology), Alessandra Cucinelli(Italian Institute of Technology), María R. Aburto(University College Cork), Maria Angela Mazzarella(Italian Institute of Technology), A. Rodríguez-Gimeno(Italian Institute of Technology)
Cited by 4
Related Papers
The blood-brain barrier in aging and neurodegeneration
|Molecular Psychiatry|2022|691
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
|Molecular and Cellular Endocrinology|2022|637
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
|Journal of Neuroendocrinology|2012|424